Vivo Bio Tech Ltd VIVOBIOT NSE
Company Profile ↓Company Overview
Vivo Bio Tech Ltd (VIVOBIOT) is a publicly traded company listed on NSE with a market capitalization of ₹41.72 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Operating margin of 20.3% supports profitability.
Recent Developments
- Mar 2026 Revenue of ₹53.33 Cr (+14.3% YoY); net profit ₹-1.71 Cr.
- Trailing 12 Months Year-on-year growth — revenue +14.3%, earnings -123.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.7%, profit CAGR -54.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.70% |
| 1 Year: | 14.27% |
Compounded Profit Growth
| 5 Years: | -54.83% |
| 1 Year: | -123.46% |
Stock Price Performance
| 1 Year: | -1.57% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Earnings shrank at -54.8% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 12.51 Cr | 13.11 Cr | 13.51 Cr | 14.20 Cr | 14.28 Cr |
| Cost of Revenue | - | 1.51 Cr | 2.09 Cr | 2.16 Cr | 2.37 Cr | 1.86 Cr |
| Gross Profit | - | 11.01 Cr | 11.01 Cr | 11.35 Cr | 11.83 Cr | 12.42 Cr |
| Operating Expenses | - | 8.16 Cr | 8.17 Cr | 8.52 Cr | 9.53 Cr | 10.90 Cr |
| Operating Income | - | 2.85 Cr | 2.84 Cr | 2.83 Cr | 2.30 Cr | 1.52 Cr |
| EBITDA | - | 5.63 Cr | 5.55 Cr | 5.63 Cr | 4.48 Cr | 5.11 Cr |
| Interest Expense | - | 1.50 Cr | 1.47 Cr | 1.40 Cr | 1.48 Cr | 1.24 Cr |
| Pretax Income | - | 1.48 Cr | 1.51 Cr | 1.57 Cr | 25.11 L | 33.86 L |
| Tax Provision | - | 14.29 L | 64.05 L | 32.16 L | 5.41 Cr | 15.10 L |
| Net Income | - | 1.34 Cr | 86.86 L | 1.25 Cr | -5.16 Cr | 18.76 L |
| Diluted EPS | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 52.23 Cr | 45.45 Cr | 46.67 Cr | 53.33 Cr |
| Cost of Revenue | - | 6.77 Cr | 3.85 Cr | 5.79 Cr | 8.13 Cr |
| Gross Profit | - | 45.46 Cr | 41.60 Cr | 40.88 Cr | 45.21 Cr |
| Operating Expenses | - | 32.89 Cr | 29.61 Cr | 29.39 Cr | 34.39 Cr |
| Operating Income | - | 12.57 Cr | 11.99 Cr | 11.49 Cr | 10.82 Cr |
| EBITDA | - | 21.54 Cr | 21.13 Cr | 25.31 Cr | 21.34 Cr |
| Interest Expense | - | 7.65 Cr | 7.78 Cr | 7.50 Cr | 5.85 Cr |
| Pretax Income | - | 4.62 Cr | 4.06 Cr | 8.79 Cr | 4.81 Cr |
| Tax Provision | - | 1.97 Cr | 1.53 Cr | 1.51 Cr | 6.52 Cr |
| Net Income | - | 2.65 Cr | 2.53 Cr | 7.28 Cr | -1.71 Cr |
| Diluted EPS | - | 1.78 | 1.51 | 4.76 | -0.82 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 123.03 Cr | 137.13 Cr | 143.23 Cr | 178.43 Cr |
| Current Assets | - | 31.79 Cr | 47.23 Cr | 41.94 Cr | 28.42 Cr |
| Cash & Equivalents | - | 1.37 Cr | 1.39 Cr | 1.28 Cr | 1.44 Cr |
| Inventory | - | 7.97 Cr | 8.77 Cr | 7.79 Cr | 8.15 Cr |
| Receivables | - | 12.38 Cr | 11.79 Cr | 11.25 Cr | 11.75 Cr |
| Total Liabilities | - | 71.16 Cr | 82.73 Cr | 65.33 Cr | 85.27 Cr |
| Current Liabilities | - | 24.97 Cr | 37.91 Cr | 27.84 Cr | 30.23 Cr |
| Long Term Debt | - | 43.09 Cr | 41.79 Cr | 34.94 Cr | 46.61 Cr |
| Total Debt | - | 62.40 Cr | 73.06 Cr | 54.02 Cr | 67.38 Cr |
| Total Equity | - | 51.87 Cr | 54.40 Cr | 77.90 Cr | 93.16 Cr |
| Shares Outstanding | - | 1.49 Cr | 1.49 Cr | 1.72 Cr | 2.22 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 14.83 Cr | 15.52 Cr | 11.83 Cr | 34.93 Cr |
| Investing Cash Flow | - | -4.00 Cr | -7.95 Cr | -15.84 Cr | -59.35 Cr |
| Financing Cash Flow | - | -11.18 Cr | -7.56 Cr | 3.90 Cr | 24.57 Cr |
| Capital Expenditure | - | -4.00 Cr | -7.95 Cr | -22.27 Cr | -37.44 Cr |
| Free Cash Flow | - | 10.84 Cr | 7.57 Cr | -10.44 Cr | -2.51 Cr |
| Net Change in Cash | - | -33.88 L | 1.49 L | -10.90 L | 15.49 L |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 87.0% | 91.5% | 87.6% | 84.8% |
| Operating Margin % | - | 24.1% | 26.4% | 24.6% | 20.3% |
| Net Margin % | - | 5.1% | 5.6% | 15.6% | -3.2% |
| ROE % | - | 5.1% | 4.6% | 9.3% | -1.8% |
| ROCE % | - | 12.8% | 12.1% | 10.0% | 7.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VIVOBIOT
Vivo Bio Tech Ltd. (VIVOBIOT) Share Price Today, Quote, Latest Discussions, Interactive Chart and News - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE9zYnZRX1d5Qm1xVHZPUVY0d2UwYkNyaXVLTFk0MElVMngwLWlmVjNwR2ZKaWs3eDNRVGZleUFVRDAtSDVPNmhRbUNLS2xMR1QwLUFOaQ?oc=5" target="_blank">Vivo Bio Tech Ltd. (VIVOBIOT) Share Price Today, Quot…
Return on invested capital % of Vivo Bio Tech Ltd. – NSE:VIVOBIOT - TradingView
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNenFPNVlxUGRKRTJhalhaWllRaXBSYll2aXYyM0taVmJ5N1BLS1ZBZWt1R1BBbHpLNG94NWNOWXo3Vl9JNVhRZGZBNHhJaE5ha0hvTnhUWXB5aGZEMjhsekN0VVAycUxBZ2dQbV80SGt4WmtJMVBBdzdfWk5xWXdDNXZZR3VlRFQ1NmE1Tl…
An undisclosed buyer acquired 5.41% stake in Vivo Bio Tech Limited from Max Cell Phone Communications Pvt. Ltd. - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOdERrem1HbVRFbm4wNS1IeFkwa2RPNnllenJJTHhFV1g0Q2ZteWJ2LTU2Z19iWXZUUzJyZ3pHWkk5Q09uUzNOYUxGWkFzWXp1YzBIUmV4QW5ZS0NqQWtQelBvdXVHRG4wM3NNOGxGTGhPalV2US1mRmRGWXl2Y3FCT09jMlNGZkl0V2V6MG…
VIVOBIOT Historical Data - Equitypandit
<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTFB0ZVBQRjhuSTFlcnMwVlByYjhPR0dqVGRJUkJReF8xTHBYOGlyMEhELWVVdXFJb08tSk9qMEpwQURuVVlPOENYdl8tU29yTk5kSlFrN0U3TWpHNC1zZEoxdm5aQQ?oc=5" target="_blank">VIVOBIOT Historical Data</a> …
Vivo Bio Tech Ltd. Share Price Declines Significantly Today - Univest
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFAzSExGMWZIWTQ0VGR4RGJoT1I1dDgtREJKMm1VbzR0b2RLWS1CeG1xS19QbnZLdXdPWlJMY3VjUDNTYmF3SXdMRTdlSy1RX2VZWFRCZXgwdGxzd19aUlFib01XNnZWX2ZFVUJwTUllTk9EWXhwRjhEWDNB?oc=5" target="_blank">Viv…
VIVOBIOT Share Price Today - Vivo Bio Tech on NSE/BSE - scanx.trade
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2Y0V5YlM4bE1zMjhzRVdoYi1sa05PVng5NmJHXzE0eWRscEdsVnVyZTVDRU8tMEJDUVlpUW1KTVR2dDF2OTZNNllZNlVYb1FDLXU1NEtWM0k?oc=5" target="_blank">VIVOBIOT Share Price Today - Vivo Bio Tech on NS…
VIVOBIOT — Frequently Asked Questions
What is the current share price of Vivo Bio Tech Ltd (VIVOBIOT)?
As of 2026-09-08 04:53 IST, Vivo Bio Tech Ltd (VIVOBIOT) trades at ₹18.80 on NSE. Its 52-week range is ₹18.11 to ₹19.29.
What is the market capitalisation of VIVOBIOT?
Vivo Bio Tech Ltd (VIVOBIOT) has a market capitalisation of ₹41.72 Cr on NSE.
What is the P/E ratio of VIVOBIOT?
VIVOBIOT trades at a trailing price-to-earnings (P/E) ratio of -22.93. Its price-to-book (P/B) ratio is 0.45.
What is the return on equity (ROE) of VIVOBIOT?
VIVOBIOT has a return on equity (ROE) of -1.83%. Its return on capital employed (ROCE) is 7.19%.
Is VIVOBIOT a good stock to buy?
This page provides a data-driven analysis of Vivo Bio Tech Ltd (VIVOBIOT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.